Paper9874475
Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis.
Scolding N and 5 others. Brain, 1998. Cited by 242 papers, by iCite.
Cite this record
ConductScience Library. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Papers, record 9874475. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9874475
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Central Nervous System | Major topic |
| Multiple Sclerosis | Major topic |
| Oligodendroglia | Major topic |
| Stem Cells | Major topic |
| Adult | |
| Brain | |
| Cells, Cultured | |
| Humans | |
| Middle Aged | |
| Receptor, Platelet-Derived Growth Factor alpha | |
| Receptors, Platelet-Derived Growth Factor | |
| Reference Values |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 9874474 | Reluctant remyelination: the missing precursors. | https://conductscience.org/library/papers/9874474 |
Source PubMed
Cited by100
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 242 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42420476 | Efficient targeting of human glial progenitor cells in vivo with engineered AAV vectors and glymphatic delivery. | Nat Biotechnol | 2026 | https://conductscience.org/library/papers/42420476 | PubMed |
| 42026046 | Charting the transition from in vitro gliogenesis to the in vivo maturation of human glial progenitor cells transplanted into the hypomyelinated mouse brain. | Nat Commun | 2026 | https://conductscience.org/library/papers/42026046 | PubMed |
| 41648527 | Critical role of cell competition in gliomagenesis. | bioRxiv | 2026 | https://conductscience.org/library/papers/41648527 | PubMed |
| 41383521 | Pilot functional magnetic resonance imaging study of clemastine-aided functional recovery on a mouse model of demyelination. | Neuroprotection | 2025 | https://conductscience.org/library/papers/41383521 | PubMed |
| 41361922 | The CEMIP Hyaluronidase is Elevated in Oligodendrocyte Progenitor Cells and Inhibits Oligodendrocyte Maturation. | ASN Neuro | 2025 | https://conductscience.org/library/papers/41361922 | PubMed |
| 41044782 | The mGluR5 agonist CHPG enhances human oligodendrocyte differentiation. | Acta Neuropathol Commun | 2025 | https://conductscience.org/library/papers/41044782 | PubMed |
| 39671488 | Nzf2 promotes oligodendrocyte differentiation and regeneration via repressing HDAC1-mediated histone deacetylation. | Sci Adv | 2024 | https://conductscience.org/library/papers/39671488 | PubMed |
| 38871922 | Trametinib, an anti-tumor drug, promotes oligodendrocytes generation and myelin formation. | Acta Pharmacol Sin | 2024 | https://conductscience.org/library/papers/38871922 | PubMed |
| 37097427 | The role of Smo-Shh/Gli signaling activation in the prevention of neurological and ageing disorders. | Biogerontology | 2023 | https://conductscience.org/library/papers/37097427 | PubMed |
| 36334067 | Glial progenitor cells of the adult human white and grey matter are contextually distinct. | Glia | 2023 | https://conductscience.org/library/papers/36334067 | PubMed |
| 36135184 | Optic Neuritis in Multiple Sclerosis-A Review of Molecular Mechanisms Involved in the Degenerative Process. | Curr Issues Mol Biol | 2022 | https://conductscience.org/library/papers/36135184 | PubMed |
| 34685659 | MicroRNAs in the Onset of Schizophrenia. | Cells | 2021 | https://conductscience.org/library/papers/34685659 | PubMed |
| 34075520 | In vivo imaging reveals mature Oligodendrocyte division in adult Zebrafish. | Cell Regen | 2021 | https://conductscience.org/library/papers/34075520 | PubMed |
| 33411219 | Thrombin generation and activity in multiple sclerosis. | Metab Brain Dis | 2021 | https://conductscience.org/library/papers/33411219 | PubMed |
| 33207780 | Efficacy of Sulforaphane in Neurodegenerative Diseases. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33207780 | PubMed |
| 32511247 | iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu. | PLoS One | 2020 | https://conductscience.org/library/papers/32511247 | PubMed |
| 32071226 | Oncostatin M-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelination. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/32071226 | PubMed |
| 31726669 | Combinatory Multifactor Treatment Effects on Primary Nanofiber Oligodendrocyte Cultures. | Cells | 2019 | https://conductscience.org/library/papers/31726669 | PubMed |
| 31069065 | An in vitro model for studying CNS white matter: functional properties and experimental approaches. | F1000Res | 2019 | https://conductscience.org/library/papers/31069065 | PubMed |
| 30796683 | Lesion Dynamics Under Varying Paracrine PDGF Signaling in Brain Tissue. | Bull Math Biol | 2019 | https://conductscience.org/library/papers/30796683 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9874475
GET https://conductscience.org/api/papers/v1/9874475/cited_by?page=2